tiprankstipranks
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market
VSBC
VitaSpring Biomedical
RESEARCH TOOLSreports

VitaSpring Biomedical (VSBC) Ratios

4 Followers

VitaSpring Biomedical Ratios

VSBC's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, VSBC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jan 26Jan 23Jan 22Jan 21
Liquidity Ratios
Current Ratio
 <0.01 <0.01 0.14 1.97 2.04
Quick Ratio
 <0.01 <0.01 0.14 1.97 2.04
Cash Ratio
 <0.01 <0.01 <0.01 0.07 0.49
Solvency Ratio
 -0.09 -0.09 -1.25 0.63 -4.57
Operating Cash Flow Ratio
 <0.01 >-0.01 -0.03 0.05 -0.45
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.46 0.00 0.00
Net Current Asset Value
$ -4.51M$ -4.43M$ -2.73M$ 1.04M$ 96.36K
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.34 0.13 0.00
Debt-to-Equity Ratio
 0.00 0.00 -0.11 0.29 0.00
Debt-to-Capital Ratio
 0.00 0.00 -0.12 0.23 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 >-0.01 >-0.01 -0.32 2.28 0.49
Debt Service Coverage Ratio
 0.00 0.00 -23.25 540.14 -633.23
Interest Coverage Ratio
 0.00 0.00 0.00 627.59 -634.90
Debt to Market Cap
 0.00 0.00 <0.01 0.00 0.00
Interest Debt Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.02 <0.01 -0.06 0.24 0.11
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%36.84%45.21%
EBIT Margin
0.00%0.00%0.00%26.43%-171.12%
EBITDA Margin
0.00%0.00%0.00%26.58%-170.94%
Operating Profit Margin
0.00%0.00%0.00%26.39%-171.39%
Pretax Profit Margin
0.00%0.00%0.00%26.39%-171.39%
Net Profit Margin
0.00%0.00%0.00%22.52%-171.39%
Continuous Operations Profit Margin
0.00%0.00%0.00%22.52%-171.39%
Net Income Per EBT
104.73%107.77%99.87%85.34%100.00%
EBT Per EBIT
100.00%100.00%99.81%100.00%100.00%
Return on Assets (ROA)
-3592.29%-2830.25%-543.69%35.07%-224.60%
Return on Equity (ROE)
9.39%9.38%173.77%80.12%-109.98%
Return on Capital Employed (ROCE)
8.70%8.70%181.40%72.34%-441.43%
Return on Invested Capital (ROIC)
8.29%8.70%195.57%61.74%-109.98%
Return on Tangible Assets
-3592.29%-2830.25%-543.69%35.07%-224.60%
Earnings Yield
-17.87%-0.20%-0.14%0.04%-0.04%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 1.90 0.00
Payables Turnover
 <0.01 <0.01 0.09 2.83 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 10.70 0.00
Asset Turnover
 0.00 0.00 0.00 1.56 1.31
Working Capital Turnover Ratio
 0.00 0.00 0.00 7.01 5.15
Cash Conversion Cycle
 -457.92K -112.28K -4.01K 63.11 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 191.96 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 457.92K 112.28K 4.01K 128.85 0.00
Operating Cycle
 0.00 0.00 0.00 191.96 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 >-0.01 >-0.01 <0.01 >-0.01
Free Cash Flow Per Share
 <0.01 >-0.01 >-0.01 <0.01 >-0.01
CapEx Per Share
 0.00 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 0.14 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -19.39K 1.16 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 -19.39K 1.16 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 -0.29 0.18 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.02 -0.17
Free Cash Flow Yield
0.18%>-0.01%>-0.01%<0.01%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.55 -500.00 -740.41 2.28K -2.57K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 513.75 4.40K
Price-to-Book (P/B) Ratio
 -0.51 -46.73 -1.29K 1.83K 2.83K
Price-to-Free Cash Flow (P/FCF) Ratio
 549.51 -77.02K -39.75K 244.10K -25.95K
Price-to-Operating Cash Flow Ratio
 549.51 -77.02K -39.76K 34.00K -25.95K
Price-to-Earnings Growth (PEG) Ratio
 0.05 0.00 1.72 -9.93 2.02
Price-to-Fair Value
 -0.51 -46.73 -1.29K 1.83K 2.83K
Enterprise Value Multiple
 -5.88 -551.41 -780.57 1.93K -2.58K
Enterprise Value
 2.29M 207.03M 3.08B 2.88B 1.09B
EV to EBITDA
 -5.88 -551.41 -780.57 1.93K -2.58K
EV to Sales
 0.00 0.00 0.00 513.81 4.40K
EV to Free Cash Flow
 547.55 -77.02K -39.76K 244.13K -25.94K
EV to Operating Cash Flow
 547.55 -77.02K -39.76K 34.01K -25.94K
Tangible Book Value Per Share
 -0.02 -0.02 -0.01 <0.01 <0.01
Shareholders’ Equity Per Share
 -0.02 -0.02 -0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.05 -0.08 <0.01 0.15 0.00
Revenue Per Share
 0.00 0.00 0.00 0.03 <0.01
Net Income Per Share
 >-0.01 >-0.01 -0.02 <0.01 >-0.01
Tax Burden
 1.05 1.08 1.00 0.85 1.00
Interest Burden
 5.17 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.10 2.16
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.03 1.75
Income Quality
 -0.01 <0.01 0.02 0.07 0.10
Currency in USD